Healthequity Inc (HQY) Expected to Post Quarterly Sales of $58.51 Million

Wall Street brokerages expect Healthequity Inc (NASDAQ:HQY) to announce $58.51 million in sales for the current fiscal quarter, according to Zacks. Eight analysts have provided estimates for Healthequity’s earnings, with estimates ranging from $57.38 million to $59.30 million. Healthequity posted sales of $46.81 million in the same quarter last year, which suggests a positive year-over-year growth rate of 25%. The company is expected to issue its next quarterly earnings report on Tuesday, March 20th.

According to Zacks, analysts expect that Healthequity will report full-year sales of $58.51 million for the current financial year, with estimates ranging from $226.46 million to $228.40 million. For the next year, analysts expect that the company will report sales of $278.89 million per share, with estimates ranging from $272.92 million to $283.90 million. Zacks Investment Research’s sales averages are an average based on a survey of research analysts that that provide coverage for Healthequity.

Healthequity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, December 5th. The company reported $0.17 EPS for the quarter, beating analysts’ consensus estimates of $0.13 by $0.04. The business had revenue of $56.80 million during the quarter, compared to the consensus estimate of $55.27 million. Healthequity had a return on equity of 14.47% and a net margin of 21.08%. The firm’s revenue was up 31.0% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.10 earnings per share.

HQY has been the subject of a number of recent analyst reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 price objective on shares of Healthequity in a report on Monday, September 25th. Citigroup started coverage on Healthequity in a research note on Thursday, January 4th. They issued a “buy” rating for the company. Zacks Investment Research raised Healthequity from a “hold” rating to a “buy” rating and set a $60.00 target price for the company in a research note on Wednesday, November 8th. Chardan Capital boosted their target price on Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research note on Wednesday, December 6th. Finally, BidaskClub raised Healthequity from a “sell” rating to a “hold” rating in a research note on Thursday, September 28th. Three investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Healthequity currently has an average rating of “Buy” and a consensus price target of $58.33.

In other news, VP Darcy G. Mott sold 9,500 shares of the company’s stock in a transaction dated Wednesday, December 20th. The stock was sold at an average price of $47.91, for a total transaction of $455,145.00. Following the completion of the transaction, the vice president now directly owns 96,500 shares of the company’s stock, valued at $4,623,315. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, major shareholder Berkley Capital, Llc sold 373,500 shares of the company’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $53.21, for a total value of $19,873,935.00. The disclosure for this sale can be found here. Over the last three months, insiders sold 1,106,934 shares of company stock valued at $57,943,828. Insiders own 29.00% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Zions Bancorporation bought a new stake in Healthequity during the third quarter worth about $119,000. Riverhead Capital Management LLC raised its holdings in Healthequity by 75.3% during the second quarter. Riverhead Capital Management LLC now owns 2,629 shares of the company’s stock worth $131,000 after acquiring an additional 1,129 shares in the last quarter. Oppenheimer Asset Management Inc. raised its holdings in Healthequity by 7.7% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,686 shares of the company’s stock worth $134,000 after acquiring an additional 191 shares in the last quarter. D.A. Davidson & CO. raised its holdings in Healthequity by 15.2% during the second quarter. D.A. Davidson & CO. now owns 3,326 shares of the company’s stock worth $165,000 after acquiring an additional 439 shares in the last quarter. Finally, CIBC Asset Management Inc bought a new stake in Healthequity during the third quarter worth about $208,000. 98.25% of the stock is owned by institutional investors.

Healthequity (NASDAQ:HQY) traded down $0.19 during midday trading on Friday, reaching $48.21. The company had a trading volume of 448,073 shares, compared to its average volume of 595,347. The company has a market capitalization of $2,930.00, a P/E ratio of 65.15, a PEG ratio of 1.99 and a beta of 1.74. Healthequity has a fifty-two week low of $37.62 and a fifty-two week high of $55.31.

TRADEMARK VIOLATION WARNING: This report was first published by Community Financial News and is owned by of Community Financial News. If you are reading this report on another website, it was illegally stolen and reposted in violation of United States and international trademark and copyright laws. The legal version of this report can be read at https://www.com-unik.info/2018/01/21/healthequity-inc-hqy-expected-to-post-quarterly-sales-of-58-51-million.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit